Bias in IGF-1 concentrations and interpretation across three different clinical laboratory assays
- 27 June 2022
- journal article
- research article
- Published by Elsevier in Clinical Biochemistry
- Vol. 108, 14-19
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Reference Values for IGF-I Serum Concentrations: Comparison of Six ImmunoassaysThe Journal of Clinical Endocrinology & Metabolism, 2016
- Interlaboratory Agreement of Insulin-like Growth Factor 1 Concentrations Measured by Mass SpectrometryClinical Chemistry, 2014
- Consensus Statement on the Standardization and Evaluation of Growth Hormone and Insulin-like Growth Factor AssaysClinical Chemistry, 2011
- The current status of IGF-I assays – A 2009 updateGrowth Hormone & IGF Research, 2010
- Acromegaly pathogenesis and treatmentJournal of Clinical Investigation, 2009
- Variation in GH and IGF‐I assays limits the applicability of international consensus criteria to local practiceClinical Endocrinology, 2007
- Serum insulin-like growth factor-I measurement in the follow-up of treated acromegaly: Comparison of four immunoassaysClinica Chimica Acta, 2006
- Variability and Reliability of single Serum IGF-I Measurements: Impact on Determining Predictability of Risk Ratios in Disease DevelopmentThe Journal of Clinical Endocrinology & Metabolism, 2004
- Increased Growth Hormone Pulse Frequency in Acromegaly*The Journal of Clinical Endocrinology & Metabolism, 1989
- Plasma Insulin-Like Growth Factor-I/Somatomedin-C in Acromegaly: Correlation With the Degree of Growth Hormone Hypersecretion*The Journal of Clinical Endocrinology & Metabolism, 1988